Skip to main content
. 2016 Jun 3;95(22):e3812. doi: 10.1097/MD.0000000000003812

TABLE 3.

Odds Ratio of Utilization of MIS to ORS for Colon and Rectal Cancer, by Baseline Patient Characteritics

graphic file with name medi-95-e3812-g004.jpg